Aggressive prolactinoma (Review).

aggressive pituitary tumor aggressive prolactinoma cabergoline hypophysectomy menses menstrual cycle pituitary carcinoma prolactin prolactinoma temozolomide

Journal

Experimental and therapeutic medicine
ISSN: 1792-1015
Titre abrégé: Exp Ther Med
Pays: Greece
ID NLM: 101531947

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 06 07 2021
accepted: 05 08 2021
entrez: 22 12 2021
pubmed: 23 12 2021
medline: 23 12 2021
Statut: ppublish

Résumé

Aggressive prolactinoma (APRL) is a subgroup of aggressive pituitary tumors (accounting for 10% of all hypophyseal neoplasia) which are defined by: invasion based on radiological and/or histological features, a higher proliferation profile when compared to typical adenomas and rapidly developing resistance to standard medication/protocols in addition to an increased risk of early recurrence. This is a narrative review focusing on APRL in terms of both presentation and management. Upon admission, the suggestive features may include increased serum prolactin with a large tumor diameter (mainly >4 cm), male sex, early age at diagnosis (<20 years), and genetic predisposition [multiple endocrine neoplasia type 1 (

Identifiants

DOI: 10.3892/etm.2021.10997 PMID: 34934445 PMC: PMC8652381
pubmed: 34934445
doi: 10.3892/etm.2021.10997
pii: ETM-0-0-10997
pmc: PMC8652381
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

74

Informations de copyright

Copyright © 2020, Spandidos Publications.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

J Med Case Rep. 2018 Dec 6;12(1):360
pubmed: 30518416
Pituitary. 2020 Feb;23(1):38-44
pubmed: 31556013
J Neurol Surg B Skull Base. 2018 Aug;79(4):394-400
pubmed: 30009121
Medicine (Baltimore). 2017 Nov;96(47):e8733
pubmed: 29381964
Maturitas. 2009 Jan 20;62(1):98-102
pubmed: 19110385
Best Pract Res Clin Endocrinol Metab. 2019 Apr;33(2):101290
pubmed: 31326373
Eur J Endocrinol. 2019 Aug;181(2):K21-K27
pubmed: 31167168
World Neurosurg. 2018 Oct;118:118-124
pubmed: 30031177
Front Endocrinol (Lausanne). 2019 May 14;10:290
pubmed: 31139150
Clin Diabetes Endocrinol. 2015 Jul 20;1:5
pubmed: 28702224
Neuroendocrinology. 2019;109(1):42-50
pubmed: 30481756
Exp Ther Med. 2020 Sep;20(3):2489-2492
pubmed: 32765740
J Med Life. 2015;8 Spec Issue:82-6
pubmed: 26361517
J Clin Med. 2020 Aug 12;9(8):
pubmed: 32806580
Neuroendocrinology. 2019;109(1):70-76
pubmed: 30943495
Neuroendocrinology. 2019;109(1):57-69
pubmed: 30677777
Endocrinol Metab Clin North Am. 2015 Mar;44(1):71-8
pubmed: 25732643
JAMA. 2021 Jan 12;325(2):195
pubmed: 33433577
Neuroendocrinology. 2019;109(1):20-27
pubmed: 30731464
J Clin Endocrinol Metab. 2019 Jun 1;104(6):1929-1936
pubmed: 30624667
Endocrinology. 2013 Mar;154(3):1247-59
pubmed: 23384836
Medicine (Baltimore). 2020 Dec 18;99(51):e23824
pubmed: 33371162
Neurosurg Clin N Am. 2019 Oct;30(4):509-514
pubmed: 31471058
Clinics (Sao Paulo). 2012;67 Suppl 1:119-23
pubmed: 22584716
J Clin Endocrinol Metab. 2021 Jan 23;106(2):e917-e925
pubmed: 33150390
Front Endocrinol (Lausanne). 2020 Nov 18;11:591501
pubmed: 33312161
J Clin Med. 2019 Dec 13;8(12):
pubmed: 31847209
Endocrine. 2020 Oct;70(1):143-149
pubmed: 32548734
Expert Rev Endocrinol Metab. 2012 Mar;7(2):233-241
pubmed: 30764014
Endocrine. 2019 Nov;66(2):310-318
pubmed: 31368083
Ann Clin Lab Sci. 2020 Mar;50(2):199-204
pubmed: 32366557
Neuroendocrinology. 2015;101(2):87-104
pubmed: 25571935
Pituitary. 2020 Feb;23(1):58-64
pubmed: 31686376
J Clin Endocrinol Metab. 2015 Mar;100(3):1177-86
pubmed: 25532043
Pituitary. 2020 Feb;23(1):70-77
pubmed: 31617128
Endocr Relat Cancer. 2019 Aug;26(9):R545-R552
pubmed: 31311005
Hum Mol Genet. 2018 Aug 1;27(15):2604-2613
pubmed: 29726992
J Clin Endocrinol Metab. 2020 Mar 1;105(3):
pubmed: 31746334
J Endocr Soc. 2020 Nov 05;5(1):bvaa171
pubmed: 33294765
Int J Mol Sci. 2020 Feb 29;21(5):
pubmed: 32121432
Eur J Endocrinol. 2019 Aug;181(2):C1-C3
pubmed: 31167164
J Pers Med. 2020 Aug 13;10(3):
pubmed: 32823651
Endocr Relat Cancer. 2009 Sep;16(3):1017-27
pubmed: 19509067
Ann Endocrinol (Paris). 2015 Feb;76(1):43-58
pubmed: 25556152
Expert Rev Endocrinol Metab. 2019 May;14(3):179-192
pubmed: 30913932
Neurol Med Chir (Tokyo). 2014;54(12):958-65
pubmed: 25446388
Ann Endocrinol (Paris). 2019 Apr;80(2):84-88
pubmed: 30318256
Endocrinol Diabetes Nutr (Engl Ed). 2020 Aug - Sep;67(7):469-485
pubmed: 31740190
J Endocr Soc. 2020 Nov 29;5(2):bvaa186
pubmed: 33392424
Hormones (Athens). 2020 Jun;19(2):145-155
pubmed: 31933100
Neuroendocrinology. 2019;109(1):51-56
pubmed: 30404098
Turk Neurosurg. 2017 May 07;:
pubmed: 28608351
Pituitary. 2020 Feb;23(1):27-37
pubmed: 31522358
Pituitary. 2020 Feb;23(1):45-51
pubmed: 31853793
Oncogene. 2017 Feb 16;36(7):979-988
pubmed: 27524416
Cancer Biol Ther. 2019;20(8):1083-1090
pubmed: 31068075
Eur J Endocrinol. 2018 Jan;178(1):G1-G24
pubmed: 29046323
Hormones (Athens). 2017 Apr;16(2):139-149
pubmed: 28742502
Rev Endocr Metab Disord. 2020 Jun;21(2):287-292
pubmed: 32064542
Case Rep Neurol. 2019 Apr 30;11(1):148-156
pubmed: 31320875
Clujul Med. 2015;88(3):310-3
pubmed: 26609262
Front Endocrinol (Lausanne). 2019 Dec 10;10:837
pubmed: 31920960
J Natl Cancer Inst. 2013 Jul 17;105(14):1005-17
pubmed: 23840053
Front Endocrinol (Lausanne). 2019 May 29;10:334
pubmed: 31191457
Expert Rev Endocrinol Metab. 2014 Nov;9(6):593-604
pubmed: 30736197
Endocrinol Metab Clin North Am. 2020 Sep;49(3):505-515
pubmed: 32741485
Ann Endocrinol (Paris). 2021 Jun;82(3-4):182-186
pubmed: 32178837
Gastrointest Cancer Res. 2012 Sep;5(5):161-8
pubmed: 23112884
Neurol India. 2020 May-Jun;68(Supplement):S13-S19
pubmed: 32611887
Pituitary. 2021 Feb;24(1):48-52
pubmed: 33010004
Oncology (Williston Park). 2018 Nov 15;32(11):555-60, 569
pubmed: 30474103
Endocrinol Metab Clin North Am. 2020 Sep;49(3):433-452
pubmed: 32741481
Pituitary. 2020 Aug;23(4):359-366
pubmed: 32232709
Endocr Connect. 2019 Apr;8(4):338-348
pubmed: 30822274
Endocrinol Metab (Seoul). 2017 Jun;32(2):162-170
pubmed: 28685507
Neuro Oncol. 2017 Jun 1;19(6):762-773
pubmed: 27543627
Endocrinol Metab Clin North Am. 2020 Sep;49(3):453-474
pubmed: 32741482
BMC Endocr Disord. 2020 May 19;20(1):68
pubmed: 32429916

Auteurs

Ana Valea (A)

Department of Endocrinology, 'I. Hatieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
Department of Endocrinology, Clinical County Hospital, 400000 Cluj-Napoca, Romania.

Florica Sandru (F)

Department of Dermatology, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Department of Dermatology, 'Elias' University Emergency Hospital, 011461 Bucharest, Romania.

Aida Petca (A)

Department of Obstetrics and Gynecology, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Department of Obstetrics and Gynecology, 'Elias' University Emergency Hospital, 011461 Bucharest, Romania.

Mihai Cristian Dumitrascu (MC)

Department of Obstetrics and Gynecology, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Department of Obstetrics and Gynecology, University Emergency Hospital, 050098 Bucharest, Romania.

Mara Carsote (M)

Department of Endocrinology, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Department of Endocrinology, 'C. I. Parhon' National Institute of Endocrinology, 011863 Bucharest, Romania.

Razvan-Cosmin Petca (RC)

Department of Urology, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Department of Urology, 'Prof. Dr. Theodor Burgele' Clinical Hospital, 061344 Bucharest, Romania.

Adina Ghemigian (A)

Department of Endocrinology, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Department of Endocrinology, 'C. I. Parhon' National Institute of Endocrinology, 011863 Bucharest, Romania.

Classifications MeSH